Patel Siddharth M, Menon Rohan V, Burke M Nicolas, Jaffer Farouc A, Yeh Robert W, Vo Minh, Karmpaliotis Dimitri, Azzalini Lorenzo, Carlino Mauro, Mashayekhi Kambis, Galassi Alfredo R, Rinfret Stephane, Ellis Stephen G, Patel Mitul, Rangan Bavana V, Karatasakis Aris, Danek Barbara A, Karacsonyi Judit, Resendes Erica, Banerjee Subhash, Brilakis Emmanouil S
Minneapolis Heart Institute, 920 E. 28th Street #300, Minneapolis, MN 55407 USA.
J Invasive Cardiol. 2018 Feb;30(2):43-50. Epub 2017 Oct 15.
We sought to examine contemporary perspectives and practices on chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
The frequency and success of CTO-PCI have been increasing in recent years.
An online questionnaire was created and distributed to cardiologists within the United States and internationally.
A total of 1149 responses were obtained. The United States (n = 845; 73.5%), Asia (n = 98; 8.5%), Europe (n = 88; 7.7%), South America (n = 42; 3.7%), and Canada (n = 33; 2.9%) accounted for most responses. Mean practice duration of the respondents was 16.4 ± 11.5 years and 66.9% were interventional cardiologists. Most respondents agreed that CTO-PCI results in an improvement of patient symptoms (90.7%), left ventricular function (79.3%), arrhythmia risk (69.2%), and overall survival (63.1%). Interventional cardiologists had a more favorable view of the benefits of CTO-PCI as compared with non-interventional cardiologists (P<.001). Most respondents estimated the procedural success rates of contemporary CTO-PCI to be between 51%-75% (34.2%) and 76%-85% (30.2%), with interventional cardiologists estimating higher success rates than non-interventionalists (P<.001). Perforation, mortality, and tamponade were the three most concerning complications. Time and procedure complexity were reported to be the most significant barriers to the development of a CTO-PCI program.
Most cardiologists believe that CTO-PCI can provide significant clinical benefits and can be accomplished with moderate to high success rates. Interventional cardiologists have a more favorable view of CTO-PCI as compared with non-invasive cardiologists.
我们试图探讨关于慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)的当代观点和实践。
近年来,CTO-PCI的频率和成功率一直在增加。
创建了一份在线问卷并分发给美国和国际的心脏病专家。
共获得1149份回复。美国(n = 845;73.5%)、亚洲(n = 98;8.5%)、欧洲(n = 88;7.7%)、南美洲(n = 42;3.7%)和加拿大(n = 33;2.9%)占了大部分回复。受访者的平均执业年限为16.4±11.5年,66.9%为介入心脏病专家。大多数受访者同意CTO-PCI能改善患者症状(90.7%)、左心室功能(79.3%)、心律失常风险(69.2%)和总体生存率(63.1%)。与非介入心脏病专家相比,介入心脏病专家对CTO-PCI益处的看法更积极(P<0.001)。大多数受访者估计当代CTO-PCI的手术成功率在51%-75%(34.2%)和76%-85%(30.2%)之间,介入心脏病专家估计的成功率高于非介入专家(P<0.001)。穿孔、死亡和心包填塞是最令人担忧的三种并发症。时间和手术复杂性被报告为CTO-PCI项目发展的最主要障碍。
大多数心脏病专家认为CTO-PCI能提供显著的临床益处,并且可以达到中到高的成功率。与非介入心脏病专家相比,介入心脏病专家对CTO-PCI的看法更积极。